糖尿病肾病中氧化应激对炎症细胞因子的影响

被引:68
作者
朱玲娜 [1 ]
唐丽琴 [2 ]
机构
[1] 安徽中医学院
[2] 安徽医科大学附属省立医院
基金
安徽省自然科学基金;
关键词
糖尿病肾病; 炎症因子; 细胞因子; 氧化应激;
D O I
暂无
中图分类号
R587.2 [糖尿病性昏迷及其他并发症]; R692.9 [其他疾病];
学科分类号
100201 [内科学]; 100221 [泌尿外科学];
摘要
糖尿病肾病是1型和2型糖尿病的主要并发症之一,它是目前终末期肾脏疾病的首要原因,高血糖是促进糖尿病肾病发生发展的主要原因。众所周知,高血糖会增加自由基的产生,并导致氧化应激。目前有越来越多的研究发现炎症在糖尿病中有着重要的作用,但关于哪些因素可以促进炎症的发生仍在不断研究中。针对氧化应激和炎症性细胞因子可以改善糖尿病肾病的治疗方案,该文重点了解糖尿病肾病中氧化应激对炎症细胞因子的影响,从而为更好地治疗糖尿病肾病提供理论基础。
引用
收藏
页码:1226 / 1229
页数:4
相关论文
共 10 条
[1]
Oral supplementation of turmeric attenuates proteinuria, transforming growth factor-β and interleukin-8 levels in patients with overt type 2 diabetic nephropathy: A randomized, double-blind and placebo-controlled study [J].
Khajehdehi, Parviz ;
Pakfetrat, Maryam ;
Javidnia, Katayoun ;
Azad, Fariborz ;
Malekmakan, Leila ;
Nasab, Mahshid Hashemi ;
Dehghanzadeh, Gholamreza .
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2011, 45 (05) :365-370
[2]
Attenuation of diabetic nephropathy by tocotrienol: Involvement of NFkB signaling pathway.[J].Anurag Kuhad;Kanwaljit Chopra.Life Sciences.2009, 9
[3]
Long-Term Treatment of Sirolimus but Not Cyclosporine Ameliorates Diabetic Nephropathy in the Rat [J].
Wittmann, Sandra ;
Daniel, Christoph ;
Stief, Andrea ;
Vogelbacher, Regina ;
Amann, Kerstin ;
Hugo, Christian .
TRANSPLANTATION, 2009, 87 (09) :1290-1299
[4]
Effects of Sildenafil on Oxidative and Inflammatory Injuries of the Kidney in Streptozotocin-Induced Diabetic Rats [J].
Jeong, Kyung-Hwan ;
Lee, Tae-Won ;
Ihm, Chun-Gyoo ;
Lee, Sang-Ho ;
Moon, Ju-Young ;
Lim, Sung-Jig .
AMERICAN JOURNAL OF NEPHROLOGY, 2009, 29 (03) :274-282
[5]
Inhibition of advanced glycation end products (AGEs): An implicit goal in clinical medicine for the treatment of diabetic nephropathy?.[J].Toshio Miyata;Takashi Dan.Diabetes Research and Clinical Practice.2008,
[6]
Proinflammatory cytokines in obesity:: Impact of type 2 diabetes mellitus and gastric bypass [J].
Catalan, Victoria ;
Gomez-Ambrosi, Javier ;
Ramirez, Beatriz ;
Rotellar, Fernando ;
Pastor, Carlos ;
Silva, Camilo ;
Rodriguez, Amaia ;
Gil, Maria J. ;
Cienfuegos, Javier A. ;
Fruehbeck, Gema .
OBESITY SURGERY, 2007, 17 (11) :1464-1474
[7]
Double-edged action of SOD mimetic in diabetic nephropathy [J].
Asaba, Kensuke ;
Tojo, Akihiro ;
Onozato, Maristela Lika ;
Goto, Atsuo ;
Fujita, Toshiro .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2007, 49 (01) :13-19
[8]
Renoprotective effects of combination of angiotensin converting enzyme inhibitor with mycophenolate mofetil in diabetic rats [J].
Wu, Y. -G. ;
Lin, H. ;
Qian, H. ;
Zhao, M. ;
Qi, X. -M. ;
Wu, G. -Z. ;
Lin, S. -T. .
INFLAMMATION RESEARCH, 2006, 55 (05) :192-199
[9]
Relationship between reduced Bcl-2 expression in circulating mononuclear cells and early nephropathy in type 1 diabetes [J].
Cipollone, F ;
Chiarelli, F ;
Iezzi, A ;
Fazia, ML ;
Cuccurullo, C ;
Pini, B ;
De Cesare, D ;
Torello, M ;
Tumini, S ;
Cuccurullo, F ;
Mezzetti, A .
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2005, 18 (04) :625-635
[10]
Diabetic nephropathy and transforming growth factor-β:: Transforming our view of glomerulosclerosis and fibrosis build-up [J].
Chen, S ;
Jim, B ;
Ziyadeh, FN .
SEMINARS IN NEPHROLOGY, 2003, 23 (06) :532-543